Nanoparticles - Metal & Metal Oxides Is Projected To Witness Growth Based On Growing Demand For Sophisticated & Effective Health Solutions Till 2025:Grand View Research,inc.
The global nanoparticles - metal & metal oxides
market in healthcare is anticipated to reach USD 80.74 billion by
2025, according to a new report by Grand View Research, Inc. Several
nanotechnologies based medicines have been put forward for approval by the FDA
which is anticipated to propel growth.
Success of nanomedicine has
prompted the development of enhanced nanomaterials for clinical applications
with particular emphasis in therapy and diagnostics. This has resulted into the
significant production of metal oxide particles that hold potential utility in
human medicine.
Remarkable evolution has been
made in nanoparticle based medicines for theranostic applications in disease
management. Diverse metals have been used for development of medicines with a
promise to optimize the efficacy of nanomedicines and to improve the current
standard of medical and clinical practices.
These particles are recognized to
have major applications in drug delivery, diagnostic products, biomarker
discovery, and product packaging. Widespread application spectrum of these
particles in maintaining human health is expected to dramatically impact the
progress of this market in the coming years.
Moreover, metal oxides are
observed to have significant role in cancer treatment. Nanoparticle-augmented
systems enable high-concentration targeted drug delivery to cancer cells, which
in turn, is expected to enhance the usage rate of metal nanoparticles for
cancer treatment. Development of drug delivery strategies using nanoparticle
approaches are expected to bring about changes effective for cancer treatment.
However, prolonged exposure of
nanoparticles adversely affects the human health as well environment thereby
restraining their adoption rate. These products are involved in autophagy,
oxidative stress, lysosome dysfunction, and the activation of certain signaling
pathways, thereby exhibiting toxicity for human health.
Browse full research report on Computer Aided Engineering
Market: http://www.grandviewresearch.com/industry-analysis/nanoparticles-metal-oxides-in-healthcare-market
Further key findings from
the report suggest:
- Presence of untapped potential in alumina and alumina
oxide particles is anticipated to create immense opportunities
- Aluminum oxide in combination with polymeric
membranes is studied for enhancement of drug delivery owing to its high
porosity property displayed in the membranes
- This enhanced efficacy of the membrane performance by
the addition of alumina nanoparticles to polymeric membranes is projected
to increase its adoption
- Approval of various nanoparticle composition and
surface properties for clinical diagnostics and treatment of viral
infections is anticipated drive market demand
- In-vivo imaging dominated the market with
respect to revenue share
- Use of antibody conjugated to Au nanorods Raman
spectrum with polarized, sharpened, and enhanced results can be attributed
for larger revenue share
- Oncology dominated over a decade and is projected to
sustain its share over the forecast period.
- Rising incidence of cancer and other chronic
multi-drug resistant diseases pronounces the demand for these particles.
- Aforementioned factor is anticipated to drive
targeted delivery with fastest YoY growth
- Asia Pacific is projected to showcase lucrative
progress in the coming years
- Key countries in the region are working to enhance
the patient’s reach to nanotechnology-based solutions
- Moreover, continuous support from the government
bodies pertaining to initiation of new projects is expected to play
crucial role for projected CAGR
- Key players contributing in this market are Pfizer
Inc., Brigham Women's Hospital (BWH), Immunolight LLC, nanoComposix,
Nanobiotix, Nanospectra Biosciences, Inc, Merck KGaA, and AstraZeneca
- These participants are investing in development of the
product portfolio that can target the chronic disorders
- Arrowhead Pharmaceuticals, Cytimmune Sciences, Inc,
Nanobiotix, Celgene Corporation, Siteman Center of Cancer Nanotechnology
Excellence (Washington University CCNE), and BIND Biosciences are few companies
that have products in the pipeline phase
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the Nanoparticles - Metal
& Metal Oxides in Healthcare Market on the basis of type, application, and
region:
Nanoparticles - Metal & Metal Oxides Type Outlook
(Revenue, USD Billion, 2013 - 2025)
- Gold
Nanoparticles
- Silver
Nanoparticles
- Iron
Oxide Nanoparticles
- Alumina
Nanoparticles
- Gadolinium
Oxide Nanoparticles
- Others
Nanoparticles - Metal & Metal Oxides Application
Outlook (Revenue, USD Billion, 2013 - 2025)
- In-vivo Imaging
- Targeted
Drug Delivery
- Proton
Therapy
- In-vitro
Assays
- Cell
& Phantom Imaging
Nanoparticles - Metal & Metal Oxides Regional Outlook
(Revenue, USD Billion, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia
Pacific
- Japan
- China
- Latin
America
- Brazil
- Middle
East and Africa (MEA)
- South
Africa
Access Press Release
By Grand View Research: http://www.grandviewresearch.com/press-release/global-nanoparticles-metal-oxides-in-healthcare-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment